Scinovex
review Open AccessTop 1% cited

Coagulase-Negative Staphylococci

Clinical Microbiology Reviews · 2014 · Vol. 27(4) · pp. 870–926
Karsten BeckerChristine HeilmannGeorg Peters

Abstract

The definition of the heterogeneous group of coagulase-negative staphylococci (CoNS) is still based on diagnostic procedures that fulfill the clinical need to differentiate between Staphylococcus aureus and those staphylococci classified historically as being less or nonpathogenic. Due to patient- and procedure-related changes, CoNS now represent one of the major nosocomial pathogens, with S. epidermidis and S. haemolyticus being the most significant species. They account substantially for foreign body-related infections and infections in preterm newborns. While S. saprophyticus has been associated with acute urethritis, S. lugdunensis has a unique status, in some aspects resembling S. aureus in causing infectious endocarditis. In addition to CoNS found as food-associated saprophytes, many other CoNS species colonize the skin and mucous membranes of humans and animals and are less frequently involved in clinically manifested infections. This blurred gradation in terms of pathogenicity is reflected by species- and strain-specific virulence factors and the development of different host-defending strategies. Clearly, CoNS possess fewer virulence properties than S. aureus, with a respectively different disease spectrum. In this regard, host susceptibility is much more important. Therapeutically, CoNS are challenging due to the large proportion of methicillin-resistant strains and increasing numbers of isolates with less susceptibility to glycopeptides.

Antimicrobial Resistance in StaphylococcusStreptococcal Infections and TreatmentsBacterial Identification and Susceptibility TestingVirulenceCoagulaseconsMicrobiologyBiologyStaphylococcus lugdunensisStaphylococcus aureusStaphylococcus saprophyticusStaphylococcal infectionsStaphylococcus epidermidis

MeSH terms

CoagulaseHumansMicrobial Sensitivity TestsStaphylococcal InfectionsStaphylococcusDisease ManagementDrug Resistance, Bacterial
Citations
1,562
FWCI
35.05
field-weighted impact
References
663
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.